Ad is loading...
LPCN
Price
$4.89
Change
-$0.32 (-6.14%)
Updated
Nov 15 closing price
ZNTL
Price
$3.47
Change
-$0.48 (-12.15%)
Updated
Nov 15 closing price
Earnings call today
Ad is loading...

LPCN vs ZNTL

Header iconLPCN vs ZNTL Comparison
Open Charts LPCN vs ZNTLBanner chart's image
Lipocine
Price$4.89
Change-$0.32 (-6.14%)
Volume$11.41K
CapitalizationN/A
Zentalis Pharmaceuticals
Price$3.47
Change-$0.48 (-12.15%)
Volume$1.83M
CapitalizationN/A
LPCN vs ZNTL Comparison Chart
Loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LPCN vs. ZNTL commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a Sell and ZNTL is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (LPCN: $4.89 vs. ZNTL: $3.47)
Brand notoriety: LPCN and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 34% vs. ZNTL: 74%
Market capitalization -- LPCN: $26.15M vs. ZNTL: $247.29M
LPCN [@Biotechnology] is valued at $26.15M. ZNTL’s [@Biotechnology] market capitalization is $247.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, LPCN is a better buy in the long-term than ZNTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 5 bullish TA indicator(s).

  • LPCN’s TA Score: 4 bullish, 5 bearish.
  • ZNTL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than LPCN.

Price Growth

LPCN (@Biotechnology) experienced а +2.73% price change this week, while ZNTL (@Biotechnology) price change was -12.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

LPCN is expected to report earnings on Aug 09, 2023.

ZNTL is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZNTL($247M) has a higher market cap than LPCN($26.2M). LPCN YTD gains are higher at: 75.269 vs. ZNTL (-77.096). LPCN has higher annual earnings (EBITDA): -8.09M vs. ZNTL (-219.22M). ZNTL has more cash in the bank: 37M vs. LPCN (22.5M). LPCN has less debt than ZNTL: LPCN (1.48M) vs ZNTL (41.3M). ZNTL has higher revenues than LPCN: ZNTL (40.6M) vs LPCN (4.8M).
LPCNZNTLLPCN / ZNTL
Capitalization26.2M247M11%
EBITDA-8.09M-219.22M4%
Gain YTD75.269-77.096-98%
P/E RatioN/AN/A-
Revenue4.8M40.6M12%
Total Cash22.5M37M61%
Total Debt1.48M41.3M4%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPCNZNTL
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 25 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EWMCX39.22-0.47
-1.18%
Evercore Equity
QISCX27.38-0.42
-1.51%
Federated Hermes MDT Small Cap Core IS
GSBAX15.01-0.28
-1.83%
Goldman Sachs Small Cap Growth C
HGOYX71.69-1.69
-2.30%
Hartford Growth Opportunities Y
LHCOX19.78-0.68
-3.32%
Lord Abbett Health Care F3

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
-6.14%
SPRY - LPCN
63%
Loosely correlated
-0.71%
IPA - LPCN
43%
Loosely correlated
-3.35%
ZNTL - LPCN
36%
Loosely correlated
-12.15%
TARA - LPCN
30%
Poorly correlated
-4.26%
CRSP - LPCN
27%
Poorly correlated
+0.85%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-12.15%
MDGL - ZNTL
51%
Loosely correlated
-4.66%
ORMP - ZNTL
43%
Loosely correlated
-4.50%
NRIX - ZNTL
40%
Loosely correlated
-14.67%
VCYT - ZNTL
39%
Loosely correlated
-2.97%
ALLO - ZNTL
38%
Loosely correlated
-7.72%
More